Vestmark Advisory Solutions’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
Other funds holding CTMX
KCM
Vestmark Advisory Solutions's CTMX Position: Q3 2026 in Review
Vestmark Advisory Solutions opened a new position in CytomX Therapeutics (CTMX) in Q3 2026: 69,637 shares worth $189K. The stake represents ﹤0.01% of the portfolio and ranks #1612 among its holdings.
172 funds tracked by Wall St. Rank hold CTMX as of Q3 2026.
- Vestmark Advisory Solutions held 69,637 shares of CytomX Therapeutics worth $189K as of Q3 2026.
- CytomX Therapeutics was a new Vestmark Advisory Solutions position in Q3 2026.
- CytomX Therapeutics made up ﹤0.01% of Vestmark Advisory Solutions's portfolio in Q3 2026, its #1612 holding.
- 172 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q3 2026.
Based on Vestmark Advisory Solutions's 13F filing for Q3 2026, filed 16 Nov 2026.